These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1526345)

  • 1. Role of cytokines in inducing hyperlipidemia.
    Feingold KR; Grunfeld C
    Diabetes; 1992 Oct; 41 Suppl 2():97-101. PubMed ID: 1526345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of cytokine induced hyperlipidemia.
    Feingold KR; Hardardóttir I; Grunfeld C
    Z Ernahrungswiss; 1998; 37 Suppl 1():66-74. PubMed ID: 9558731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance.
    Feingold KR; Staprans I; Memon RA; Moser AH; Shigenaga JK; Doerrler W; Dinarello CA; Grunfeld C
    J Lipid Res; 1992 Dec; 33(12):1765-76. PubMed ID: 1479286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats.
    Feingold KR; Soued M; Adi S; Staprans I; Shigenaga J; Doerrler W; Moser A; Grunfeld C
    Diabetes; 1990 Dec; 39(12):1569-74. PubMed ID: 1978829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of interleukin-1 on lipid metabolism in the rat. Similarities to and differences from tumor necrosis factor.
    Feingold KR; Soued M; Adi S; Staprans I; Neese R; Shigenaga J; Doerrler W; Moser A; Dinarello CA; Grunfeld C
    Arterioscler Thromb; 1991; 11(3):495-500. PubMed ID: 2029492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tumor necrosis factor (TNF) on lipid metabolism in the diabetic rat. Evidence that inhibition of adipose tissue lipoprotein lipase activity is not required for TNF-induced hyperlipidemia.
    Feingold KR; Soued M; Staprans I; Gavin LA; Donahue ME; Huang BJ; Moser AH; Gulli R; Grunfeld C
    J Clin Invest; 1989 Apr; 83(4):1116-21. PubMed ID: 2703526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages.
    Persson J; Nilsson J; Lindholm MW
    Lipids Health Dis; 2006 Jun; 5():17. PubMed ID: 16800873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis.
    Feingold KR; Doerrler W; Dinarello CA; Fiers W; Grunfeld C
    Endocrinology; 1992 Jan; 130(1):10-6. PubMed ID: 1370149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.
    Bilz S; Samuel V; Morino K; Savage D; Choi CS; Shulman GI
    Am J Physiol Endocrinol Metab; 2006 Apr; 290(4):E716-22. PubMed ID: 16291572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids.
    Bartolomé N; Rodríguez L; Martínez MJ; Ochoa B; Chico Y
    Ann N Y Acad Sci; 2007 Jan; 1096():55-69. PubMed ID: 17405916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition.
    Krauss RM; Grunfeld C; Doerrler WT; Feingold KR
    Endocrinology; 1990 Sep; 127(3):1016-21. PubMed ID: 2387245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lipid metabolism by cytokines during host defense.
    Grunfeld C; Feingold KR
    Nutrition; 1996 Jan; 12(1 Suppl):S24-6. PubMed ID: 8850215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for two classes of cytokines that stimulate hepatic lipogenesis: relationships among tumor necrosis factor, interleukin-1 and interferon-alpha.
    Grunfeld C; Soued M; Adi S; Moser AH; Dinarello CA; Feingold KR
    Endocrinology; 1990 Jul; 127(1):46-54. PubMed ID: 1972922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
    Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins.
    De Sanctis JB; Blanca I; Bianco NE
    Immunology; 1997 Apr; 90(4):526-33. PubMed ID: 9176105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid disorders in diabetes.
    Goldberg RB
    Diabetes Care; 1981; 4(5):561-72. PubMed ID: 6751732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis.
    Levy E; Gurbindo C; Lacaille F; Paradis K; Thibault L; Seidman E
    Pediatr Res; 1993 Aug; 34(2):162-6. PubMed ID: 8233719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion.
    Feingold KR; Serio MK; Adi S; Moser AH; Grunfeld C
    Endocrinology; 1989 May; 124(5):2336-42. PubMed ID: 2707158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.